Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06074341 · ClinicalTrials.gov registry record · NA

TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study

A NA study of Alcohol Use Disorder and Alcohol Drinking, sponsored by University of New Mexi.

Active
Registry status
NA
Development phase
470
Enrollment target
1
Study location

NCT06074341: Active NA study of Alcohol Use Disorder and Alcohol Drinking, sponsored by University of New Mexi.

NCT06074341 is a NA study of Alcohol Use Disorder and Alcohol Drinking that is active but no longer recruiting, run by University of New Mexi. The registered enrollment target is 470 participants, above the 326-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (44% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06074341, a NA study of Alcohol Use Disorder and Alcohol Drinking, is active but no longer recruiting, sponsored by University of New Mexi.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
470 participants
Enrollment target
1
Study location

Study Summary

This project will evaluate the effectiveness and mechanisms of mindfulness-based relapse prevention (MBRP) delivered via video conferencing, as compared to referral to online mutual support groups, in supporting long-term whole-person recovery and improvements in neurobiologically-informed domains of addiction among individuals with alcohol use disorder who are interested in reducing or stopping drinking. The project will also examine the reach, effectiveness, adoption, implementation, and maintenance of MBRP as an accessible and freely available continuing care option that supports long-term recovery from alcohol use disorder in all communities nationwide, including medically underserved and health professional shortage areas.

Primary Outcome

Recovery is a binary (yes/no) outcome defined by achieving all three of the following: (1) Remission from Diagnostic and Statistical Manual, 5th edition alcohol use disorder (AUD) based on an 11-item AUD symptom checklist (endorsing 0 or 1 item is AUD remission); (2) Cessation of heavy drinking (defined as not engaging in heavy drinking over the past 28 days with heavy drinking defined as 4 or more drinks per occasion for females, and 5 or more drinks per occasion for males, measured by the Time

Interventions

  • BEHAVIORAL Mindfulness-based relapse prevention
  • BEHAVIORAL Online Mutual Support Groups

Study Locations (1)

New Mexico

  • University of New Mexico - Albuquerque

Trial Details

FieldValue
Enrollment Target 470 participants
Start Date 2023-09-13
Est. Completion 2028-07-31
Phase NA
University of New Mexi

76 total trials

What the registry record for NCT06074341 still lists

NCT06074341 is an interventional study that assigns participants to a tested intervention. The registered 470 participants enrollment target is mid-sized for trials with a published cap, above the 326-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (44% higher).

The record links to 3 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness-based relapse prevention is the first listed.

NCT06074341 reports a single indexed study location in New Mexico.

Frequently Asked Questions

What is clinical trial NCT06074341 about?

NCT06074341 is a clinical study titled "TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study". This project will evaluate the effectiveness and mechanisms of mindfulness-based relapse prevention (MBRP) delivered via video conferencing, as compared to referral to online mutual support groups, in supporting long-term whole-person recovery and improvements in neurobiologically-informed domains o...

What is the current status of trial NCT06074341?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 470 participants. The study started on 2023-09-13. Estimated completion is 2028-07-31.

What conditions does trial NCT06074341 study?

This clinical trial studies the following conditions: Alcohol Use Disorder, Alcohol Drinking, Alcohol-Related Disorders.

What interventions are being tested in trial NCT06074341?

The interventions under investigation include: Mindfulness-based relapse prevention (BEHAVIORAL), Online Mutual Support Groups (BEHAVIORAL).

Who is sponsoring clinical trial NCT06074341?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06074341 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06074341's enrollment target sits among peer trials

470 16th of 184 higher than 169 of 184 other Alcohol Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05256940 · 470 participants · NA

    Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide

  • NCT05458219 · 470 participants · Phase 1

    A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

  • NCT05850689 · 470 participants · Phase 3

    Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  • NCT05935384 · 470 participants

    SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06074341, the US trial registry maintained by the National Library of Medicine. NCT06074341 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.